Newbury Pharmaceuticals AB(SE:NEWBRY)
kr 2.01-0.01 (-0.50%)
SE:NEWBRY
Newbury Pharmaceuticals AB Revenue
kr 2.01
At close:-0.01 (-0.50%)
Newbury Pharmaceuticals AB (NEWBRY) Revenue
0 Followers
Newbury Pharmaceuticals AB Revenue
Newbury Pharmaceuticals AB had a revenue of 12.43M in the quarter ending Feb 28, 2025, with 90.18%. This bring the company's revenue in the last twelve months to 41.48M, Increased 28.90%. In the fiscal year ending Aug 31, 2024, Newbury Pharmaceuticals AB had annual revenue of 36.83M with 258.75% growth.
- Revenue (ttm)
- 41.48M
- Revenue Growth
- ―
- P/S Ratio
- 1.67
- Revenue/Employee
- SEK 5,261,286
- Employees
- 7
- Market Cap
- SEK 61.40M
Revenue Chart
Newbury Pharmaceuticals AB Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2024 | 36.83M | 26.56M | 258.75% |
| Aug 31, 2023 | 10.27M | 4.75M | 86.11% |
| Aug 31, 2022 | 5.52M | 2.69M | 94.98% |
| Aug 31, 2021 | 2.83M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.